| Tag | Content |
|---|
EnhancerAtlas ID | HS095-17108 |
Organism | Homo sapiens |
Tissue/cell | HMEC |
Coordinate | chr2:145439260-145441700 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Myod1 | MA0499.1 | chr2:145440710-145440723 | AGCAGCTGTTGCC | + | 6.34 | | TP63 | MA0525.2 | chr2:145440236-145440254 | CACATGTACTGACTTGTC | - | 6.25 | | Tcf12 | MA0521.1 | chr2:145440709-145440720 | CAGCAGCTGTT | - | 6.32 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09166 | chr2:145438881-145448498 | CD14 | | SE_61928 | chr2:145428817-145468056 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 4 | Chromosome | Start | End |
| chr2 | 145439552 | 145440370 | | chr2 | 145439912 | 145440212 | | chr2 | 145440674 | 145441287 | | chr2 | 145440709 | 145440835 |
|
| | Number: 3 | ID | Chromosome | Start | End |
| GH02I144682 | chr2 | 145439912 | 145440212 | | GH02I144684 | chr2 | 145441567 | 145441860 | | GH02I144683 | chr2 | 145440554 | 145441428 |
|
Enhancer Sequence | TTGTGTATCT ACTTGGTATC AAACACATAG GTAGTCATGT AAAAATTAAA GAGAAATAAT 60
TTATAAAGTC TTTGTCCATA AGAAGTTTTC AGTTTATTTG TGGAGATATC ATAGGTTGAC 120
TTTAAAAGAA CCAGTGGACC AAATATGAGT GCTAGGGAAA ATACGTTTAG CCTGAACTCA 180
GTGTGGGTGA GGTTAGGTGA AACCAGTTTA AAGGATAGGT ATTTGGTTGA AAGATGTGGC 240
TCTGTTACCA GTGAGATCTA GCTTTGAATT CTTGTTCTCC CACACACTGG CTATGTAAAT 300
TCAGCCAAAT TTCTTAACCC CTGAAAGCTT TTCTCTTTTT GTTACAATTT TCTCATGGAT 360
CACATTAGGT CAGGCAGATA ATGTGCTTCA CACATAGTAA GCAGTCAATA CACGTAATTC 420
ATTTCTAAGG CACACTCATC GTTTGTGCCT TACAGAATTG AGCTTTCTTA CACTTTCTCT 480
AGCCCCAAAA TGACTTCTGA AGCTTAAGTT TCTCCTCTTT AATGAGATAC TTCATTTGTT 540
TTTATACTGT CCAAAATTGA GTTCGATGGA ACAGATTCAT ATTTATTGAT GAATACAAAA 600
GAGACATTGT AAAAATATTT CCATGTTCTT CTTATCATAT GACATTTACA CTTCAAACAG 660
ATTTATGAGC TAGTGCGTGG TTAATTATAG CTATGCAGAG ATGGATATGT AAGCGTTGCC 720
TGGGCGGGTT TGTGCTGTCA TGGTGGGAGT GACCAGAGCT GGGTGGGGTT ATCTGAGAGA 780
GACTTGTTCT TTGCCTACTC ATGGAACACT TCTGAGGCTT TAATGAGAAG CTAGATCTAA 840
ATGTCAGAAG TGGATCCAAA GTCAAGATAA TTCAAGTTAC AATGTGACAC CCTATTTCAA 900
GGAAGAAGGA ATAAGCAAAC AAACAACCCA ACAAACATCT TAAAGTTTTC AGGACTATTG 960
TGCTTGCCAG TGATGCCACA TGTACTGACT TGTCTTGGAA ATTAACCATT GTTGATTTTA 1020
GCAGCACATT TCTCTACTTT CTCTGATTTC TTGTTTTATC ATAATTCAAT GGTGTTTTCT 1080
TTCTTCTGGG CCTTCTCAGT GCTGTACTTG CAGAGTATTT TATCTTTTGT CTAAATAAGA 1140
ACACTAAATA TTTGGCCCAC TGGCTCAGAA GCCAGTTTCT CTAAGCCAAA AATTGTCTCT 1200
ACTGTCTAAT TTTTAAGGCT GTATTTTAAA ATGCTTCTTA TTCACTAGTG AGAAAATTAC 1260
AAAATGCACT ATTAAAAAAA CATGAGGTTT GTGCCACTTA GAGAATGTAT TCTATGCACC 1320
AAAACACCCA TTGTTCATAT TTAGAGATGC CCCTAAATAT AGATGTACTG AACTACCTAC 1380
ATATAATTCA GATCATGTCA AAGCACAAAC CCCTCTCAGT GTGGGGTAGT GTGGGCATTT 1440
TGTTATCTAC AGCAGCTGTT GCCTCATTTT GAGGGTAAAA AACCTACTCC TGTTTAAATT 1500
TATGTTGCAT TGAGCAAGTT GTATTGCTTG CGATTATATG TGGCTCAGCT GTGTCACGTG 1560
GCGTGACCTG CTATAACCTG CCTTAATGCA GTCCACATGT TGTACTGAAT GACACACATT 1620
AAAACATTCC ACTTCTCCAT GGAACTGTGT GAGCAGGTGA TTTCTCTAAA TGGCAGACAC 1680
TCGCATGCTT GTATTTTAAA CCTCCACCAG TTTAGCTAAA AATATCTTCA AAAGCCCACC 1740
CAAAACATTT CCCATGGTTA TTTTTGCAAA TCGTTGGGTG ACTTACAAAG AGCAGGGAGG 1800
GATGCATAAG AGGAAGTTTT AAATTATTTA CATAATTTGA TAGAACGGTG CCTCCTTTAA 1860
AAAATCTACT TTGTGGAAGT CACAAAAAAG AACTTTACTT CACATAATCA GAGTCCTAGG 1920
GAGGGGACCC AGTCATATGA TTATTAGCTT GCTGCTGCTT GGATTCCAGC AAGTTGATGA 1980
TTATATTTCT CATCAAGCTA AATGTAAAAA TAATGAAAAA TTACTGTGTC CCAGCAAACA 2040
ACCCTCATAG GAATGCACAC TATTTTTACC AATATTTTTA TCCCTCCTGT GTGAGAACAG 2100
AGGGCACCAT TTGTCCTGAA TTCACCTTGA AGTGTTTGGT CATCAGTGAT AAAATTTTGT 2160
ATTGAGCCAC TGGTTCATTC GGTGACCAAA GGAACACATT GGTAGCACAA TTTGGAGCAG 2220
AATTCTTCTT TGTTATTAAG CAAAGTAACC TAAACAAGAT CTAACATATA TATAGTCCCA 2280
GTTTCTCCAG CATCATGCTC TTACCAAGTG AGGCAATTAG CCAGTTGTAT GGCATGGAAA 2340
AGAGATCTGA GCACCGTGAG CAAGCACAAG TCTGGGAGTT GAGCATACTG CTCAAATCCC 2400
AGTTGTAGTT CCAGCATGTA GTAGCTGGGC AACCCGGTGC 2440
|
